$250 | Single User
$500 | Site License
$750 | Global License

Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

Published by Global Data: 24 Jul 2018 | 215498 | In Stock

Introduction

Summary

Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vaccine candidates using its proprietary Themaxyn vaccine platform with a vaccine vector system, loaded with antigens from a variety of non - infectious and infectious targets. Themis Bioscience develops innovative vaccine candidates for infectious diseases such as dengue, chikungunya and yellow fever virus. The company markets its products in Austria and abroad. Themis Bioscience is headquartered in Vienna, Austria.

Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 4

    List of Figures 4

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

    Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deal Details 10

    Venture Financing 10

    Themis Bioscience Raises USD12 Million in Series C Venture Financing 10

    Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11

    Themis Bioscience Raises USD7.8 Million in Series B Financing 12

    Partnerships 13

    Themis Bioscience Enters into Partnership with CEPI 13

    Themis Bioscience GmbH - Key Competitors 14

    Themis Bioscience GmbH - Key Employees 15

    Themis Bioscience GmbH - Locations And Subsidiaries 16

    Head Office 16

    Recent Developments 17

    Corporate Communications 17

    Feb 26, 2018: Themis Establishes Scientific Advisory Board of Experts in Virology and Vaccine Development 17

    Product News 19

    06/05/2017: NIAID-Sponsored Trial of Experimental Chikungunya Vaccine Begins 19

    Clinical Trials 20

    Apr 11, 2017: Zika Virus: Themis Bioscience Initiates Worldwide First Study With Live Attenuated Recombinant Vaccine 20

    Appendix 21

    Methodology 21

    About GlobalData 21

    Contact Us 21

    Disclaimer 21

List Of Tables
in Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

List of Tables

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Key Facts 2

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Themis Bioscience GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Themis Bioscience GmbH, Deals By Therapy Area, 2012 to YTD 2018 8

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Themis Bioscience Raises USD12 Million in Series C Venture Financing 10

Themis Bioscience Secures USD10.58 Million in Series B Funding Round 11

Themis Bioscience Raises USD7.8 Million in Series B Financing 12

Themis Bioscience Enters into Partnership with CEPI 13

Themis Bioscience GmbH, Key Competitors 14

Themis Bioscience GmbH, Key Employees 15

List Of Figures, Charts and Diagrams
in Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018]

List of Figures

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Themis Bioscience GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Additional Details

Publisher

Global Data

Publisher Information

Reference

215498 | GDPH310773D

Number of Pages

21

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Themis Medicare Ltd (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd (Themis Medicare) is a pharmaceutical company that manufactures and marke...
15 May 2017 by Global Data USD $300 More Info
Themis Medicare Ltd (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd (Themis Medicare) is a pharmaceutical company that manufactures and marke...
13 Jan 2017 by Global Data USD $300 More Info
Gujarat Themis Biosyn Ltd (506879) - Financial and Strategic SWOT Analysis Review
SummaryGujarat Themis Biosyn Ltd (GTBL) is a medicinal products company that develops, manufactures,...
13 Jan 2017 by Global Data USD $300 More Info
Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryThemis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylac...
13 Dec 2016 by Global Data USD $250 More Info
Themis Medicare Ltd. (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd. (Themis Medicare) is a pharmaceutical company that manufactures and mark...
11 Jul 2016 by Global Data USD $300 More Info
Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryThemis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylac...
12 May 2016 by Global Data USD $250 More Info
Themis Medicare Ltd. (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd. (Themis Medicare) is a pharmaceutical company that manufactures and mark...
15 Apr 2016 by Global Data USD $300 More Info
Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryThemis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylac...
17 Mar 2016 by Global Data USD $250 More Info
Themis Medicare Ltd. (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd. (Themis Medicare) is a pharmaceutical company that manufactures and mark...
09 Jan 2016 by Global Data USD $300 More Info
Themis Medicare Ltd. (THEMISMED) - Financial and Strategic SWOT Analysis Review
SummaryThemis Medicare Ltd. (Themis Medicare) is a pharmaceutical company that manufactures and mark...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Global Data

Download Free Report Summary PDF

Themis Bioscience GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 24-07-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data